Cite

    Amat, T., Gutiérrez-Pizarraya, A., Machuca, I., Gracia-Ahufinger, I., Pérez-Nadales, E., Torre-Giménez, Á., Garnacho-Montero, J., Cisneros, J., & Torre-Cisneros, J. (2018). the combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii. Clinical microbiology and infection, 24, 630–634. http://access.bl.uk/ark:/81055/vdc_100063975932.0x00001c